ADM Tronics Unlimited, Inc. (OTCMKTS:ADMT) has advanced to a new 52-week high of $0.27 on continual advancements the company has made. ADMT closed at its high of day and the stock has seen a significant inflow of money. The company recently reported double digit growth in its third quarter 2016 financial results.
In mid-February, ADM Tronics Unlimited, Inc. (OTCMKTS:ADMT) reported its 3rd Quarter Fiscal Year 2016 results. It saw revenue climb 64% to $1.1 million from $0.68 million in the same period prior and net income doubled from $0.114 million to $0.237 million. Revenues for the nine months ending Dec 31, 2015 climbed 64% as well from $2.05 million in the year prior to $3.354 million in the current reporting period. Net income surged over 300% increasing from $0.3 million to $1.18 million.
According the president of the company, Andre’ DiMino, stated, “Our medical device engineering segment is expected to continue to fuel the revenue success that we have experienced in our ongoing quarter over quarter financial growth. We foresee the development of proprietary medical device projects going forward contributing to the maturation of our business and technology planning and solidifying revenues and profit, with positive cash flow from operations.”
Mr. DiMino also commented, “”As we attract new clients and expand our Engineering Services and Product Development, we can expect our client base and device mix to diversify,” said Mr. DiMino, “We will continue to champion the development and production of less and non-invasive technologies, and to manage the process of bringing them through regulatory approval.”
Gross profit for the three months ended December 31, 2015 increased by $299,174. Gross profit for the nine months ended December 31, 2014 increased by $1,041,248. Income from operations for the three months ended December 31, 2015 increased by $123,410. Net cash provided by operating activities was $863,846 for the nine months ended December 31, 2015, as compared to net cash provided by operating activities of $149,840 for the nine months ended December 31, 2014.
ADM Tronics Unlimited, Inc. develops and manufactures a diversified line of technology products. The Company’s products include therapeutic, non-invasive electronic medical devices, as well as environmentally safe chemical products and topical dermatological products. ADMT operates through several subsidies, Pegasus Laboratories, Inc. (Pegasus), Sonotron Medical Systems, Inc. (SMI) and Action Industries Unlimited LLC (Action). The Company’s products and services include industrial, medical and cosmetic products, electronics for medical and other applications and research, development, regulatory and engineering services.
ADMT is currently trading at a $17 million market valuation. It is showing explosive growth through its new product line and continues to improve its financial performance significantly. The company has a trailing twelve months P/E ratio of only 14.
We have a Monster Pick Coming. Subscribe Right Now!
We will be updating on ADMT when more details emerge so make sure you are subscribed to Microcapspot so you know what’s going on with ADMT.
Disclosure: we hold no position in ADMT either long or short at the publication of this article and we have not been compensated for this article.